The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer Tsukasa SeyaMisako Matsumoto Review 31 January 2009 Pages: 1175 - 1184
Breast cancer cells expressing stem cell markers CD44+ CD24lo are eliminated by Numb-1 peptide-activated T cells Takashi MineSatoko MatsuedaConstantin G. Ioannides Original Article 02 December 2008 Pages: 1185 - 1194
Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model Asahi ItoTakashi IshidaRyuzo Ueda Original Article Open access 02 December 2008 Pages: 1195 - 1206
TGF-alpha as a candidate tumor antigen for renal cell carcinomas Sandy PelletierSimon TanguayRéjean Lapointe Original Article 04 December 2008 Pages: 1207 - 1218
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy Robbert G. van der MostAndrew J. CurrieRichard A. Lake Original Article 04 December 2008 Pages: 1219 - 1228
A cell-based high-throughput screen to identify synergistic TRAIL sensitizers Nancy Lynn BoothThomas J. SayersCurtis J. Henrich Original Article 17 December 2008 Pages: 1229 - 1244
A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth Tomoe HiguchiMasumi ShimizuHidemi Takahashi Original Article Open access 13 January 2009 Pages: 1245 - 1255
Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches Terry J. FryJessica L. ShandCrystal L. Mackall Original Article 13 January 2009 Pages: 1257 - 1264
Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients Valeska Hofmeister-MuellerClaudia S. Vetter-KauczokJuergen C. Becker Original Article Open access 13 January 2009 Pages: 1265 - 1273
Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis Cai ZhangYiping WangZhigang Tian Original Article 13 January 2009 Pages: 1275 - 1285
Ablation of T cell immunity differentially influences tumor risk in inbred BD rat strains Judith A. M. MarxAnsgar J. RöhrbornAndrea Kindler-Röhrborn Original Article 13 January 2009 Pages: 1287 - 1295
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases Anna Maria Di GiacomoRiccardo DanielliMichele Maio Original Article 13 January 2009 Pages: 1297 - 1306
Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential Mizue TeraiYutaka TamuraTakami Sato Original Article 14 January 2009 Pages: 1307 - 1317
Secretion of stress protein grp170 promotes immune-mediated inhibition of murine prostate tumor Ping GaoXiaolei SunXiang-Yang Wang Original Article 14 January 2009 Pages: 1319 - 1328
Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines Adam S. GiermaszJulie A. UrbanPawel Kalinski Original Article 21 January 2009 Pages: 1329 - 1336
Memory and cellular immunity induced by a DNA vaccine encoding self antigen TPD52 administered with soluble GM-CSF Jennifer D. LewisLaura A. SullivanRobert K. Bright Original Article 24 January 2009 Pages: 1337 - 1349
Immune-mediated red cell aplasia after anti-CTLA-4 immunotherapy for metastatic melanoma Ilyssa O. GordonTakisha WadeThomas F. Gajewski Letter to the Editors 04 December 2008 Pages: 1351 - 1353
